Bio
Titus has >25 years of experience leading life sciences organizations in operational, corporate development, product planning and commercial roles. Currently Titus heads up a neuroscience company Viage Therapeutics, and is executive in residence for Cleveland Clinic Innovations. During his tenure at Tranquis Therapeutics he closed a $30M Series A. His executive positions include Chief Operating Officer at early development stage companies, VP of Corporate Development at Bavarian Nordic, and senior marketing and commercial positions at Tolerx, Therion Biologics, Biogen and Amgen. Mr. Plattel has a MSc from Radboud University in the Netherlands and an MBA from Pepperdine Graziado Business School.